Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure

Phase 2 Completed 66 enrolled CG Oncology, Inc.

NaSingle-groupOpen-labelTreatment

Summary

To study the safety and efficacy of CG0070, an oncolytic virus expression GM-CSF in high grade non muscle invasive bladder cancer patients who failed BCG therapy and refused cystectomy.

Timeline

Start: 2015-06-02
Primary completion: 2018-08
Completion: 2019-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cretostimogene Grenadenorepvec	Unknown	1e+12 unknown	Other

Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure

Summary

Timeline

Drugs

Indications